Sandra F. Falkenhein

Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.

Barbara A. Jakschik, Sandra F. Falkenhein, C W Parker · Proceedings of the National Academy of Sciences · 1977 · 184 citations · Full text

Molecular Pharmacology, Oxysterol, Arachidonic Acid Metabolism +14

Release of arachidonic acid from human lymphocytes in response to mitogenic lectins.

C W Parker, James P. Kelly, Sandra F. Falkenhein et al. · The Journal of Experimental Medicine · 1979 · 91 citations · Full text

Inflammation, Human Lymphocytes, Free Arachidonic Acid +15

Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187

Charles W. Parker, Sandra F. Falkenhein, Mary Huber · Prostaglandins · 1980 · 82 citations

Aldo-keto Reductase, Glutathionyl Side Chain, Biochemistry +8

Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity

Charles W. Parker, Mary Huber, Michael K. Hoffman et al. · Prostaglandins · 1979 · 71 citations

Biochemistry, Major Species, Medicine +9

Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasma

Charles W. Parker, Del A. Koch, Mary Huber et al. · Biochemical and Biophysical Research Communications · 1980 · 50 citations

Biochemistry, Medicine, Physiology +7